Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

@article{Bostom1995HyperhomocysteinemiaAT,
  title={Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.},
  author={Andrew G. Bostom and Douglas G. Shemin and Kate L. Lapane and Joshua W. Miller and Patrice Sutherland and Marie Nadeau and E Seyoum and Woltemade Hartman and Roger Prior and Peter W. F. Wilson},
  journal={Atherosclerosis},
  year={1995},
  volume={114 1},
  pages={93-103}
}
Hyperhomocysteinemia occurs frequently in end-stage renal disease (ESRD), but its prevalence in comparison with traditional cardiovascular disease (CVD) risk factors is unknown. Fasting total plasma homocysteine, potential determinants of plasma homocysteine (i.e., plasma B-vitamins and serine), total and HDL cholesterol, glucose, and creatinine, were determined in 24 ESRD patients on dialysis, and 24 age, gender, and race matched Framingham Offspring Study controls with normal renal function… CONTINUE READING
45 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

Similar Papers

Loading similar papers…